3rd Circuit Affirms Dismissal Of Drug Rebate False Claims Act Suit

(August 20, 2018, 11:33 AM EDT) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals on Aug. 16 affirmed dismissal of a whistleblower lawsuit accusing eight drug manufacturers of miscalculating their drug prices and shorting rebates owed to Medicaid (United States, et al., ex rel. Ronald J. Streck v. Allergan, Inc., et al., No. 17-1014, 3rd Cir., 2018 U.S. App. LEXIS 22762)....

Attached Documents

Related Sections